The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism
Abstract
Primary aldosteronism is the most frequent cause of endocrine hypertension. Three forms of familial hyperaldosteronism (FH) have been described, named FH-I to -III. Recently, a mutation of KCNJ5 has been shown to be associated with FH-III, whereas the cause of FH-II is still unknown. In this study we searched for mutations in KCNJ5 in 46 patients from 21 families with FH, in which FH-I was excluded. We identified a new germline G151E mutation in 2 primary aldosteronism–affected subjects from an Italian family and 3 somatic mutations in aldosterone-producing adenomas, T158A described previously as a germline mutation associated with FH-III, and G151R and L168R both described as somatic mutations in aldosterone-producing adenoma. The phenotype of the family with the G151E mutation was remarkably milder compared with the previously described American family, in terms of both clinical and biochemical parameters. Furthermore, patients with somatic KCNJ5 mutations displayed a phenotype indistinguishable from that of sporadic primary aldosteronism. The functional characterization of the effects of the G151E mutation in vitro showed a profound alteration of the channel function, with loss of K + selectivity, Na + influx, and membrane depolarization. These alterations have been postulated to be responsible for voltage gate Ca 2+ channel activation, increase in cytosolic calcium, and stimulation of aldosterone production and adrenal cell proliferation. In conclusion, we describe herein a new mutation in the KCNJ5 potassium channel associated with FH-III, responsible for marked alterations of channel function but associated with a mild clinical and hormonal phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Funder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism
Geller, D. S., Zhang, J., Wisgerhof, M. V., Shackleton, C., Kashgarian, M., & Lifton, R. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0594 · Cited by 296
Cited by
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Scholl, U. I., Stölting, G., Nelson-Williams, C., Vichot, A. A., Choi, M., Loring, E., Prasad, M. L., Goh, G., Carling, T., Juhlin, C. C., et al. (2015) · eLife · doi:10.7554/elife.06315 · Cited by 358
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 325
Åkerström, T., Crona, J., Delgado Verdugo, A., Starker, L. F., Cupisti, K., Willenberg, H. S., Knoefel, W. T., Saeger, W., Feller, A., Ip, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041926 · Cited by 188
Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma
Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03346 · Cited by 151
Metadata
- Authors
- Mulatero, P., Tauber, P., Zennaro, M.-C., Monticone, S., Lang, K., Beuschlein, F., Fischer, E., Tizzani, D., Pallauf, A., Viola, A., Amar, L., Williams, T. A., Strom, T. M., Graf, E., Bandulik, S., Penton, D., Plouin, P.-F., Warth, R., Allolio, B., Jeunemaitre, X., Veglio, F., & Reincke, M.
- Venue
- Hypertension
- Published
- 2012-02
- Volume
- 59
- Issue
- 2
- Pages
- 235-240
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2125261314
- Cited by
- 196
- References
- 2
- FWCI
- 15.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism. https://app.cochat.ai/papers/10.1161/hypertensionaha.111.183996
- The paper
- Mulatero, P., Tauber, P., Zennaro, M.-C., Monticone, S., Lang, K., Beuschlein, F., Fischer, E., Tizzani, D., Pallauf, A., Viola, A., Amar, L., Williams, T. A., Strom, T. M., Graf, E., Bandulik, S., Penton, D., Plouin, P.-F., Warth, R., Allolio, B., . . . Reincke, M. (2012). KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism. Hypertension. https://doi.org/10.1161/hypertensionaha.111.183996
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.